What is Jazz Pharmaceuticals plc worth?
With the base-case assumptions below, a discounted cash flow model on Jazz Pharmaceuticals plc's reported free cash flow gives $545.13 per share. The share price was $245.43 on November 10, 2026, 55% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 7.5% | 10.0% | $315.57 | +29% |
| Base | 12.5% | 9.0% | $545.13 | +122% |
| Bull | 17.5% | 8.0% | $1,002.53 | +308% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $720.75 | $775.17 | $841.68 | $924.81 | $1,031.71 |
| 8.0% | $589.08 | $624.37 | $666.08 | $716.13 | $777.29 |
| 9.0% | $493.16 | $517.29 | $545.13 | $577.61 | $616.00 |
| 10.0% | $420.33 | $437.49 | $456.94 | $479.16 | $504.80 |
| 11.0% | $363.26 | $375.84 | $389.90 | $405.71 | $423.64 |
Where the presets come from
Base: years 1 to 5 grow at Jazz Pharmaceuticals plc's revenue growth rate over the last 5 fiscal years (12.5% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions